Literature DB >> 6308174

Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents.

R H Kimberlin, C A Walker, G C Millson, D M Taylor, P A Robertson, A H Tomlinson, A G Dickinson.   

Abstract

A variety of disinfection procedures were tested on two strains of scrapie agent, treated either as brain macerates (autoclaving) or as 10% homogenates (chemical treatments). It is suggested that a given treatment should produce a titre loss, of both strains of scrapie, of at least 10(4) units before it be regarded as useful for the disinfection of the agents of scrapie and Creutzfeldt-Jakob disease (CJD). By this criterion, treatment at room temperature with about 4% Hycolin (0.6% chlorinated phenols), 0.2% permanganate, 5% Tego (dodecyl-di(aminoethyl)-glycine) or 5% sodium dodecyl sulphate (SDS) are unsuitable. However, data indicate that SDS might be used to reduce the heat stability of scrapie agent. Hypochlorite (Sterilex) was the only satisfactory chemical reagent tested. At least 10(4)-10(5) units of infectivity were lost by treatment with hypochlorite containing 1,000 ppm available chlorine after a 4-16 h exposure, or containing 10,000 ppm available chlorine after a half-hour exposure. The latter result points to the use of concentrated hypochlorite (about 2% available chlorine; approximately 20% Sterilex) to decontaminate surfaces. We suggest that the cleaning action of SDS, or other strong detergents, might also help to decontaminate surfaces, but studies on this are needed. Autoclaving at 126 degrees C for 1-2 h reduced titres by 10(3)-10(7) units, depending on the strain of agent. However, total disinfection of brain containing high titres of infectivity was approached only at 136 degrees C when titre losses of about 10(6) units were obtained by autoclaving for 4-32 min. Further studies are needed before we can make simple, general recommendations for the disinfection of CJD agents in hospital practice.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308174     DOI: 10.1016/0022-510x(83)90021-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

1.  Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.

Authors:  F Taguchi; Y Tamai; K Uchida; R Kitajima; H Kojima; T Kawaguchi; Y Ohtani; S Miura
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Purification of non-infectious ganglioside preparations from scrapie-infected brain tissue.

Authors:  A Di Martino; J Safar; M Ceroni; C J Gibbs
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.

Authors:  Susanne DiSalvo; Tricia R Serio
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

4.  Autoclaved, formol-fixed scrapie mouse brain is suitable for histopathological examination, but may still be infective.

Authors:  D M Taylor; P A McBride
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Kinetics of ozone inactivation of infectious prion protein.

Authors:  Ning Ding; Norman F Neumann; Luke M Price; Shannon L Braithwaite; Aru Balachandran; Gordon Mitchell; Miodrag Belosevic; Mohamed Gamal El-Din
Journal:  Appl Environ Microbiol       Date:  2013-02-15       Impact factor: 4.792

6.  Inactivation of prions by acidic sodium dodecyl sulfate.

Authors:  David Peretz; Surachai Supattapone; Kurt Giles; Julie Vergara; Yevgeniy Freyman; Pierre Lessard; Jiri G Safar; David V Glidden; Charles McCulloch; Hoang-Oanh B Nguyen; Michael Scott; Stephen J Dearmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Adsorption and decontamination of α-synuclein from medically and environmentally-relevant surfaces.

Authors:  Hanh T M Phan; Jason C Bartz; Jacob Ayers; Benoit I Giasson; Mathias Schubert; Keith B Rodenhausen; Negin Kananizadeh; Yusong Li; Shannon L Bartelt-Hunt
Journal:  Colloids Surf B Biointerfaces       Date:  2018-03-09       Impact factor: 5.268

Review 8.  Bovine spongiform encephalopathy (BSE): the current situation and research.

Authors:  R Bradley
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

9.  Can potential hazard of Creutzfeldt-Jakob disease infectivity be reduced in the production of human growth hormone? Inactivation experiments with the 263K strain of scrapie. Rapid communication.

Authors:  M Pocchiari; G Macchi; S Peano; A Conz
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

10.  Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie.

Authors:  D M Taylor; H Fraser; I McConnell; D A Brown; K L Brown; K A Lamza; G R Smith
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.